Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Athersys Inc (NQ: ATHX )

1.240 -0.070 (-5.32%)
Streaming Delayed Price Updated: 2:43 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Athersys Inc

< Previous 1 2 Next >
Athersys Expands IP Protection with First New Patent for SIFU® Technology
From Athersys, Inc.
Via Business Wire
Athersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion
From Athersys, Inc.
Via Business Wire
Athersys to Host Business Update Conference Call on February 14th
From Athersys, Inc.
Via Business Wire
Athersys to Participate in International Stroke Conference and BioProcess International
From Athersys, Inc.
Via Business Wire
Athersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in January
From Athersys, Inc.
Via Business Wire
Athersys Provides MultiStem Clinical Update
From Athersys, Inc.
Via Business Wire
Athersys Appoints Joseph Nolan to Its Board of Directors
From Athersys, Inc.
Via Business Wire
Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update
From Athersys, Inc.
Via Business Wire
Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital Conference and Participate in A.G.P.’s Biotech Conference
From Athersys, Inc.
Via Business Wire
Athersys, Inc. Announces Closing of $5.5 Million Confidentially Marketed Public Offering
From Athersys, Inc.
Via Business Wire
Athersys Reschedules Third Quarter Conference Call to November 15
From Athersys, Inc.
Via Business Wire
Athersys, Inc. Announces Pricing of $5.5 Million Public Offering
From Athersys, Inc.
Via Business Wire
Athersys, Inc. Announces Proposed Public Offering
From Athersys, Inc.
Via Business Wire
Athersys to Host Third Quarter Financial Results Call
From Athersys, Inc.
Via Business Wire
Athersys to Present at 2022 Cell & Gene Meeting on the Mesa Conference and Attend 14th World Stroke Congress in October
From Athersys, Inc.
Via Business Wire
Athersys to Host Business Update Conference Call on October 6th
From Athersys, Inc.
Via Business Wire
Athersys Amends Securities Purchase Agreement in Connection with Recent Registered Direct Offering
From Athersys, Inc.
Via Business Wire
Athersys Announces 1-for-25 Reverse Stock Split
From Athersys, Inc.
Via Business Wire
Athersys, Inc. Announces Closing of $12 Million Registered Direct Offering
From Athersys, Inc.
Via Business Wire
Athersys, Inc. Announces $12 Million Registered Direct Offering
From Athersys, Inc.
Via Business Wire
Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update
From Athersys, Inc.
Via Business Wire
Athersys Announces Favorable Preclinical Results for MultiStem® Treatment in Defense Department Radiation Countermeasure Study and Upcoming Webinar to Review Preclinical Research With MultiStem Across Multiple Indications
From Athersys, Inc.
Via Business Wire
Athersys Appoints Kasey Rosado as Interim Chief Financial Officer
From Athersys, Inc.
Via Business Wire
Athersys to Host Second Quarter Financial Results Call
From Athersys, Inc.
Via Business Wire
Athersys and Aspire Capital Fund Terminate Relationship
From Athersys, Inc.
Via Business Wire
Athersys Announces Board of Directors Slate for 2022 Annual Meeting of Stockholders and Director Departures
From Athersys, Inc.
Via Business Wire
Athersys Postpones Annual Meeting of Stockholders
From Athersys, Inc.
Via Business Wire
Athersys Hosting KOL Panel Event to Discuss TREASURE Data
From Athersys, Inc.
Via Business Wire
Athersys Announces Restructuring and Management Changes to Focus on Its Existing Clinical Programs
From Athersys, Inc.
Via Business Wire
Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE Multistem Ischemic Stroke Study
From Athersys, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.